145 related articles for article (PubMed ID: 2221232)
1. Survival discriminants for differentiated thyroid cancer.
Cunningham MP; Duda RB; Recant W; Chmiel JS; Sylvester JA; Fremgen A
Am J Surg; 1990 Oct; 160(4):344-7. PubMed ID: 2221232
[TBL] [Abstract][Full Text] [Related]
2. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Mazzaferri EL; Jhiang SM
Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
[TBL] [Abstract][Full Text] [Related]
3. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
5. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns].
Hundahl SA; Fleming ID; Fremgen AM; Menck HR
Cancer; 1998 Dec; 83(12):2638-48. PubMed ID: 9874472
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of papillary and follicular thyroid carcinoma.
Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma of the thyroid in children--a review.
Feinmesser R; Lubin E; Segal K; Noyek A
J Pediatr Endocrinol Metab; 1997; 10(6):561-8. PubMed ID: 9467125
[TBL] [Abstract][Full Text] [Related]
8. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
McHenry C; Jarosz H; Lawrence AM; Paloyan E
Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
Yang Z; Flores J; Katz S; Nathan CA; Mehta V
Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
[TBL] [Abstract][Full Text] [Related]
10. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
11. Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor.
Schelfhout LJ; Creutzberg CL; Hamming JF; Fleuren GJ; Smeenk D; Hermans J; van de Velde CJ; Goslings BM
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):331-7. PubMed ID: 3356216
[TBL] [Abstract][Full Text] [Related]
12. Analysis of risk of death from differentiated thyroid cancer.
Ruiz de Almodóvar JM; Ruiz-García J; Olea N; Villalobos M; Pedraza V
Radiother Oncol; 1994 Jun; 31(3):207-12. PubMed ID: 8066203
[TBL] [Abstract][Full Text] [Related]
13. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
14. Radiation-Induced Differentiated Thyroid Cancer Is Associated with Improved Overall Survival but Not Thyroid Cancer-Specific Mortality or Disease-Free Survival.
White MG; Cipriani NA; Abdulrasool L; Kaplan S; Aschebrook-Kilfoy B; Angelos P; Kaplan EL; Grogan RH; Onel K
Thyroid; 2016 Aug; 26(8):1053-60. PubMed ID: 27279587
[TBL] [Abstract][Full Text] [Related]
15. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
16. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
Bhattacharyya N
Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
[TBL] [Abstract][Full Text] [Related]
17. Thyroid cancer. Survival in 148 cases followed for 10 years or more.
Torres J; Volpato RD; Power EG; Lopez EC; Dominguez ME; Maira JL; Ugarte JA; Martinez VC
Cancer; 1985 Nov; 56(9):2298-304. PubMed ID: 4052973
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in differentiated carcinoma of the thyroid gland.
Shah JP; Loree TR; Dharker D; Strong EW; Begg C; Vlamis V
Am J Surg; 1992 Dec; 164(6):658-61. PubMed ID: 1463119
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
20. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.
Seaberg RM; Eski S; Freeman JL
Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):355-9. PubMed ID: 19380356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]